Press Releases

Amniox Medical Introduces RESPINA™ at NASS 2017

RESPINA umbilical cord/amniotic membrane matrix for microdiscectomy earns 2017 Spine Technology Award ORLANDO – October 26, 2017 – Amniox Medical, Inc., a TissueTech, Inc. company, highlighted the introduction of RESPINA its cryopreserved umbilical cord/amniotic membrane matrix at the North American Spine Society’s (NASS) annual meeting in Orlando, FL, October 25 – 27. Amniox Medical’s proprietary […]


TissueTech Inc. Awarded Four Patents for Proprietary Technology to Use Placental Tissue for Regenerative Medicine

Company has more than 40 issued patents MIAMI – September 14, 2017 – TissueTech Inc. announced today that it has been awarded four patents by the U.S. Patent Trademark Office. Two of the patents cover methods of promoting bone formation and the others cover methods for lyophilizing and sterilizing placental tissue. “TissueTech continues to maintain […]


TissueTech, Inc. Names John Arnott, Industry Executive, to Board of Directors

Arnott brings experience in a wide range of global healthcare businesses MIAMI – August 3, 2017 – TissueTech Inc. announced today that it has named John Arnott to its Board of Directors. Mr. Arnott was most recently Operating Partner and Executive Chairman of multiple portfolio companies for The Riverside Company, one of largest and oldest […]


TissueTech, Inc. Names Dr. Herbert B. Slade as Chief Medical Officer

MIAMI – August 1, 2017 – TissueTech, Inc. announced today that Herbert B. Slade, MD, has been named the company’s Chief Medical Officer (CMO). Dr. Slade, who will lead the execution of TissueTech’s clinical research strategies and be the primary liaison for medical affairs, has more than 25 years of healthcare industry-based experience, most recently […]


Study Demonstrating Improved Outcomes in Pain Reduction and Function for Discectomy Patients with CLARIX® 100 Highlighted in Medical Journal

Proprietary technology demonstrates significant improvement in short-term and long-term outcomes ATLANTA – July 10, 2017 – Amniox Medical, Inc., a TissueTechTM, Inc. company, announced today that the results of a clinical study on the efficacy of CLARIX Cryopreserved Amniotic Membrane in lumbar microdiscectomy surgery was published in the May 2017 online issue of Clinical Spine […]


Amniox Medical Enters into Agreement with Intalere

ATLANTA, GA – June 8, 2017 – Amniox Medical, Inc., a TissueTech, Inc. company has announced an agreement with Intalere, to serve their members with its market leading human tissue allograft technology composed of both umbilical cord and amniotic membrane for wound healing and soft-tissue repair. Intalere is a professional supply chain company offering a […]


New Clinical Evidence Continues to Support the Effectiveness and Value of Amniox Medical Products

Nine Posters Demonstrating the Clinical Benefits of NEOX ® Wound Allograft Presented at SAWC ATLANTA, GA – May 8, 2017 – Amniox Medical, Inc., a TissueTech, Inc. company, announced today that nine clinical posters demonstrating the effectiveness of NEOX® Wound Allograft – Amniox’s proprietary cryopreserved Umbilical Cord and Amniotic Membrane (UC/AM) product for chronic wound […]


Amniox Obtains Federal Supply Schedule Contract for NEOX® and CLARIX® Product Lines

Expanded Access to Industry-Leading Technology for 10.2 Million Military Personnel ATLANTA, GA – April 17, 2017 — Amniox Medical, Inc., a TissueTech, Inc. company, announced a new Federal Supply Schedule contract for its NEOX and CLARIX product lines. The agreement provides the Military Health System broad access to NEOX Wound Allograft – indicated for use […]


Amniox Highlights Three Studies Demonstrating Effectiveness of Umbilical Cord Tissue for Treating Chronic Wounds

Studies Document Healing Rates of 78% – 87% ATLANTA, GA – April 7, 2017 — Amniox Medical, Inc., a TissueTech, Inc. company, highlighted the publication of three studies concerning NEOX CORD 1K, its cryopreserved human umbilical cord tissue. In contrast to competitive offerings, these studies document the consistent effectiveness of the Company’s proprietary technology in […]


AMNIOX Study Confirms Benefits of CLARIX FLO for Plantar Fasciitis

ATLANTA – March 30, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company, announced today the results of a study demonstrating the application of its unique cryopreserved human umbilical cord tissue for the treatment of patients with plantar fasciitis. The findings were recently presented at the American College of Foot and Ankle Surgeons in Las Vegas. In this study, forty-three […]